1,720,966 research outputs found
sj-docx-1-msj-10.1177_13524585231195346 – Supplemental material for Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585231195346 for Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension by Stephen L Hauser, Ronald Zielman, Ayan Das Gupta, Jing Xi, Dee Stoneman, Goeril Karlsson, Derrick Robertson, Jeffrey A Cohen and Ludwig Kappos in Multiple Sclerosis Journal</p
sj-docx-8-msj-10.1177_13524585221083194 – Supplemental material for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
No full textSupplemental material, sj-docx-8-msj-10.1177_13524585221083194 for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years by Bruce AC Cree, Douglas L Arnold, Robert J Fox, Ralf Gold, Patrick Vermersch, Ralph HB Benedict, Amit Bar-Or, Daniela Piani-Meier, Nicolas Rouyrre, Shannon Ritter, Ajay Kilaru, Goeril Karlsson, Gavin Giovannoni and Ludwig Kappos in Multiple Sclerosis Journal</p
sj-docx-4-msj-10.1177_13524585221083194 – Supplemental material for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
No full textSupplemental material, sj-docx-4-msj-10.1177_13524585221083194 for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years by Bruce AC Cree, Douglas L Arnold, Robert J Fox, Ralf Gold, Patrick Vermersch, Ralph HB Benedict, Amit Bar-Or, Daniela Piani-Meier, Nicolas Rouyrre, Shannon Ritter, Ajay Kilaru, Goeril Karlsson, Gavin Giovannoni and Ludwig Kappos in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585221083194 – Supplemental material for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585221083194 for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years by Bruce AC Cree, Douglas L Arnold, Robert J Fox, Ralf Gold, Patrick Vermersch, Ralph HB Benedict, Amit Bar-Or, Daniela Piani-Meier, Nicolas Rouyrre, Shannon Ritter, Ajay Kilaru, Goeril Karlsson, Gavin Giovannoni and Ludwig Kappos in Multiple Sclerosis Journal</p
sj-docx-2-msj-10.1177_13524585221083194 – Supplemental material for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
No full textSupplemental material, sj-docx-2-msj-10.1177_13524585221083194 for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years by Bruce AC Cree, Douglas L Arnold, Robert J Fox, Ralf Gold, Patrick Vermersch, Ralph HB Benedict, Amit Bar-Or, Daniela Piani-Meier, Nicolas Rouyrre, Shannon Ritter, Ajay Kilaru, Goeril Karlsson, Gavin Giovannoni and Ludwig Kappos in Multiple Sclerosis Journal</p
sj-pdf-9-msj-10.1177_13524585221083194 – Supplemental material for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
No full textSupplemental material, sj-pdf-9-msj-10.1177_13524585221083194 for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years by Bruce AC Cree, Douglas L Arnold, Robert J Fox, Ralf Gold, Patrick Vermersch, Ralph HB Benedict, Amit Bar-Or, Daniela Piani-Meier, Nicolas Rouyrre, Shannon Ritter, Ajay Kilaru, Goeril Karlsson, Gavin Giovannoni and Ludwig Kappos in Multiple Sclerosis Journal</p
sj-docx-5-msj-10.1177_13524585221083194 – Supplemental material for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
No full textSupplemental material, sj-docx-5-msj-10.1177_13524585221083194 for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years by Bruce AC Cree, Douglas L Arnold, Robert J Fox, Ralf Gold, Patrick Vermersch, Ralph HB Benedict, Amit Bar-Or, Daniela Piani-Meier, Nicolas Rouyrre, Shannon Ritter, Ajay Kilaru, Goeril Karlsson, Gavin Giovannoni and Ludwig Kappos in Multiple Sclerosis Journal</p
sj-docx-7-msj-10.1177_13524585221083194 – Supplemental material for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
No full textSupplemental material, sj-docx-7-msj-10.1177_13524585221083194 for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years by Bruce AC Cree, Douglas L Arnold, Robert J Fox, Ralf Gold, Patrick Vermersch, Ralph HB Benedict, Amit Bar-Or, Daniela Piani-Meier, Nicolas Rouyrre, Shannon Ritter, Ajay Kilaru, Goeril Karlsson, Gavin Giovannoni and Ludwig Kappos in Multiple Sclerosis Journal</p
sj-docx-6-msj-10.1177_13524585221083194 – Supplemental material for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
No full textSupplemental material, sj-docx-6-msj-10.1177_13524585221083194 for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years by Bruce AC Cree, Douglas L Arnold, Robert J Fox, Ralf Gold, Patrick Vermersch, Ralph HB Benedict, Amit Bar-Or, Daniela Piani-Meier, Nicolas Rouyrre, Shannon Ritter, Ajay Kilaru, Goeril Karlsson, Gavin Giovannoni and Ludwig Kappos in Multiple Sclerosis Journal</p
sj-docx-3-msj-10.1177_13524585221083194 – Supplemental material for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years
No full textSupplemental material, sj-docx-3-msj-10.1177_13524585221083194 for Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years by Bruce AC Cree, Douglas L Arnold, Robert J Fox, Ralf Gold, Patrick Vermersch, Ralph HB Benedict, Amit Bar-Or, Daniela Piani-Meier, Nicolas Rouyrre, Shannon Ritter, Ajay Kilaru, Goeril Karlsson, Gavin Giovannoni and Ludwig Kappos in Multiple Sclerosis Journal</p
- …
